FDA Expert Panel on Selective Serotonin Reuptake Inhibitors (SSRIs) and Pregnancy

Panelists:
- Anick Bérard, Ph.D. — Professor of Perinatal Epidemiology, University of Montreal, Faculty of Pharmacy, and CHU Ste-Justine in Montreal; and Adjunct Professor at the Faculty of Medicine, Université Claude Bernard
- Jay Gingrich, M.D., Ph.D. — Director, Institute for Developmental Sciences, Professor of Developmental Psychology (in Psychiatry), Columbia University Irving Medical Center
- David Healy, M.D., Fellow of the Royal College of Psychiatrists — Founder and CEO of Data Based Medicine, North Wales, UK (formerly Professor of Psychiatry at McMaster University in Canada, and Bangor and Cardiff Universities in the UK)
- Jeffrey Lacasse, Ph.D., M.S.W. — Associate Professor, College of Social Work, Florida State University
- Michael Levin, Ph.D. (virtual) — Distinguished Professor, Department of Biology and Director of the Allen Discovery Center at Tufts University
- Roger McFillin, Psy.D., — American Board of Professional Psychology
Clinical Psychologist, Executive Director of the Center for Integrated Behavioral Health
- Joanna Moncrieff, M.D. (virtual) — Professor of Critical and Social Psychiatry at University College London and practising psychiatrist
- Kay Roussos-Ross, M.D. — Professor and Chief, Division Academic Specialists in General Obstetrics and Gynecology, Director of Perinatal Mood Disorders Program, Department of Obstetrics and Gynecology and Psychiatry, University of Florida College of Medicine
- Adam Urato, M.D. — Chief, Maternal-Fetal Medicine, MetroWest Medical Center
- Josef Witt-Doerring, M.D. — Psychiatrist, Taperclinic (Former FDA Medical Officer)